Predictable cash flow is the whole game. In cannabis, predictable is the one thing almost nobody has.
Organigram CEO James Yamanaka came up over 20 years at British American Tobacco, where that discipline is the entire m...

Germany Is the Engine: What BAT Knows That Cannabis Doesn't ft. James Yamanaka

Investing in cannabis requires a split personality.
Everyone thinks they're early. Dan McDermitt has been trading the sector for 15 years — through the Canadian boom, the Biden promise, and the slow bleed that followed. ...

15 Years of Cannabis Trading . Why I'll Sell Early (Unless This Happens) ft. Dan McDermitt

Debt is coming due — and we’re approaching a point of no return.At this stage, it’s not if there will be fallout — it’s who survives it.The surface-level view of the cannabis industry hides deep financial issues that onl...

The Cannabis Titanic: The Reset Ahead, Matt Karnes on What the Numbers Say

Built to last.That’s not just a slogan — it’s a strategy.In an industry driven by short-term survival, the cannabis space often feels like a rollercoaster. Financial pressures and market volatility push companies to chas...

Organigram’s Competitive Edge: Paolo De Luca on BAT, M&A Strategy, and the Cannabis Long Game

What if the most powerful investor pitch wasn’t a deck or a breakdown of earnings—but a story?Now, the idea of seeds in the ground to thriving plants is a tangible experience—one that finally captures the real narrative....

Storytelling Is the Future of Cannabis IR ft Jesse Redmond

There’s no exits. There’s no cash. There’s no buyers. So what do you do? Batten down the hatches. Crush your market. Squeeze out the little guys who can’t compete — and wait.This week, Seth Yakatan returns to discuss the...

Investor Perspective